샘플 요청 목록

 카트 문의
시장보고서
상품코드
1643330

MIS 천장관절 고정술 시장

MIS Sacroiliac Joint Fusion
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 467 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

MIS 천장관절 고정술 세계 시장은 2030년까지 17억 달러에 달할 전망

2024년 8억 6,810만 달러로 추정되는 MIS 천장관절 고정술 세계 시장은 2024-2030년 분석 기간 동안 연평균 11.5% 성장하여 2030년에는 17억 달러에 달할 것으로 예상되며, MIS 천장관절 고정술 보고서에서 분석된 부문 중 하나인 임플란트 부문은 연평균 12.5%의 성장률을 기록할 것으로 예상됩니다. 은 CAGR 12.5%를 기록하여 분석 기간 말까지 13억 달러에 달할 것으로 예상되며, MIS 천장관절 고정술 기기 및 장비 부문의 성장률은 분석 기간 동안 CAGR 8.6%로 추정됩니다.

미국 시장은 2억 3,650만 달러, 중국은 CAGR 15.8%로 성장 전망

미국의 MIS 천장관절 고정술 시장은 2024년 2억 3,650만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2024년부터 2030년까지 연평균 15.8%의 CAGR을 기록하여 2030년까지 3억 5,070만 달러의 시장 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 8.3%와 10.3%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 약 9.1%의 CAGR로 성장할 것으로 예상됩니다.

세계 MIS 천장관절 고정술 시장 - 주요 동향 및 촉진요인 요약

MIS 천장관절 고정술이 헬스케어 분야에서 인기를 끄는 이유는?

최소침습적 천장관절(SI) 고정술은 천장관절 기능 장애로 인한 만성 요통으로 고통받는 환자들을 위한 획기적인 솔루션으로 등장했습니다. 퇴행성 천장관절염, 외상, 관절염 등의 치료가 대중화되면서 효과적인 치료 옵션에 대한 수요가 증가하고 있습니다. 기존의 수술적 접근법과는 달리, 최소침습적 기술은 회복 시간 단축, 절개 부위 축소, 수술 후 불편감 감소로 환자와 의료진 모두에 의해 점점 더 선호되고 있습니다. 또한, SI 관절의 기능 장애에 취약한 고령화 인구의 증가도 MIS 시술의 채택을 촉진하는 주요 요인으로 작용하고 있습니다. 또한, 천장관절 문제의 조기 진단 및 치료의 다른 이점에 대한 인식이 높아짐에 따라 고급 수술에 대한 수요가 급증하여 이 시장의 성장을 더욱 촉진하고 있습니다.

기술의 발전은 MIS 천장관절 고정술에 어떤 혁명을 가져오고 있는가?

의료 기술의 발전은 MIS 천장관절 고정술 시장의 급격한 성장의 최전선에 있습니다. 영상 진단 및 내비게이션 시스템의 혁신은 수술 정확도를 크게 향상시키고 합병증 위험을 줄이며 환자 결과를 개선했습니다. 티타늄 및 생체 활성 물질과 같은 새로운 임플란트 재료의 개발은 임플란트의 내구성과 통합성을 향상시켜 더 나은 회복과 장기적인 결과를 가져 왔습니다. 로봇 보조 수술과 컴퓨터 보조 계획 도구는 수술을 더욱 간소화하여 외과 의사가 최소침습으로 더 높은 정확도를 달성할 수 있도록 돕고 있습니다. 또한, 수술 계획에 증강현실(AR)을 통합함으로써 외과의사가 복잡한 사례를 시각화하고 접근하는 방식을 변화시키고 있습니다. 이러한 발전은 임상 효율성을 향상시킬 뿐만 아니라 MIS 수술을 선택하는 환자들의 신뢰도를 높여 시장 성장을 촉진하고 있습니다.

시장 궤도를 형성하는 지역 역학은 무엇인가?

MIS 천장관절 고정술 시장은 다양한 의료 인프라, 경제 상황, 환자 인구통계에 따라 지역별로 불균등하게 확대되고 있습니다. 북미는 높은 의료비 지출, 확립된 상환 프레임워크, 첨단 의료기술의 가용성으로 인해 시장을 지배하고 있습니다. 유럽은 천장관절 질환의 유병률 증가와 최소침습 수술에 대한 선호도 증가에 힘입어 꾸준한 성장세를 보이고 있습니다. 반면, 아시아태평양은 헬스케어 투자 증가, SI 관절 기능 장애에 대한 인식 증가, 급속한 고령화로 인해 잠재력이 큰 시장으로 급성장하고 있습니다. 인도, 중국 등 신흥국 정부는 의료 접근성 확대에 힘쓰고 있으며, 이는 시장 침투 기회를 창출하고 있습니다. 또한, 중동 및 아프리카에서는 의료 인프라의 개선과 의료관광의 증가로 MIS 기술이 점차적으로 채택되고 있습니다.

MIS 천장관절 고정술 시장의 성장 원동력은?

MIS 천장관절 고정술 시장의 성장은 수술 기술의 발전과 환자의 선호도 변화 등 여러 요인에 의해 주도되고 있습니다. 특히 노년층과 운동량이 많은 사람들 사이에서 요통 및 관련 질환의 유병률이 증가함에 따라 효과적이고 최소침습적인 치료에 대한 수요가 증가하고 있습니다. 의료 인프라에 대한 투자와 R&D 이니셔티브의 증가는 보다 효율적이고 환자 친화적인 수술 도구와 임플란트 개발을 촉진하고 있습니다. 조기 개입의 이점에 대한 의료 전문가들의 인식이 높아짐에 따라 이러한 시술의 채택률이 증가하고 있습니다. 또한, 선진국의 유리한 상환 정책 및 신흥 시장에서의 전문 수술의 가용성 확대는 시장 성장에 기여하고 있습니다. 이러한 요인들이 복합적으로 작용하여 MIS 천장관절 고정술은 증가하는 의료 수요에 효율적이고 효과적으로 대응할 수 있는 큰 잠재력을 가지고 있습니다.

부문

제품(MIS 천장관절 고정술 임플란트, MIS 천장관절 고정술 기구 및 장비), 접근법(후방 접근법, 전방 접근법), 적응증(퇴행성 천장관절염 적응증, 외상 적응증, 천장관절 기능부전 적응증), 최종 용도(병원용, 외래 수술 센터 최종 용도, 기타 최종 용도)

조사 대상 기업 예시(주목받는 44개 기업)

  • Camber Spine Technologies, LLC
  • CoreLink Surgical
  • CornerLoc
  • Globus Medical, Inc.
  • Life Spine, Inc.
  • Medtronic Plc
  • Microspine PLC
  • Orthofix Medical Inc.
  • PainTEQ
  • SI-BONE, Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.02.12

Global MIS Sacroiliac Joint Fusion Market to Reach US$1.7 Billion by 2030

The global market for MIS Sacroiliac Joint Fusion estimated at US$868.1 Million in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 11.5% over the analysis period 2024-2030. MIS Sacroiliac Joint Fusion Implants, one of the segments analyzed in the report, is expected to record a 12.5% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the MIS Sacroiliac Joint Fusion Instruments & Equipment segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$236.5 Million While China is Forecast to Grow at 15.8% CAGR

The MIS Sacroiliac Joint Fusion market in the U.S. is estimated at US$236.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$350.7 Million by the year 2030 trailing a CAGR of 15.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.3% and 10.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.

Global MIS Sacroiliac Joint Fusion Market - Key Trends & Drivers Summarized

Why Is MIS Sacroiliac Joint Fusion Gaining Popularity in the Healthcare Sector?

Minimally invasive sacroiliac (SI) joint fusion has emerged as a transformative solution for patients suffering from chronic lower back pain caused by sacroiliac joint dysfunction. The growing prevalence of conditions such as degenerative sacroiliitis, trauma, and arthritis has amplified the demand for effective treatment options. Unlike traditional surgical approaches, minimally invasive techniques offer reduced recovery times, smaller incisions, and less post-operative discomfort, making them increasingly preferred by both patients and healthcare providers. The global rise in aging populations, who are more susceptible to SI joint dysfunction, is also a significant factor driving the adoption of MIS techniques. Additionally, the increasing awareness of the benefits of early diagnosis and treatment of sacroiliac joint issues has led to a surge in demand for advanced surgical procedures, further propelling the growth of this market.

How Are Technological Advancements Revolutionizing MIS Sacroiliac Joint Fusion?

Advances in medical technology are at the forefront of the rapid growth in the MIS sacroiliac joint fusion market. Innovations in imaging and navigation systems have significantly enhanced surgical precision, reducing the risk of complications and improving patient outcomes. The development of novel implant materials, such as titanium and bioactive substances, has improved the durability and integration of implants, fostering better recovery and long-term results. Robotic-assisted surgeries and computer-aided planning tools are further streamlining procedures, enabling surgeons to achieve higher accuracy with minimal invasiveness. Moreover, the integration of augmented reality (AR) in surgical planning is transforming how surgeons visualize and approach complex cases. These advancements not only improve clinical efficiency but also increase patient confidence in opting for MIS procedures, thus driving market growth.

What Are the Regional Dynamics Shaping the Market's Trajectory?

The market for MIS sacroiliac joint fusion is expanding unevenly across regions, shaped by diverse healthcare infrastructures, economic conditions, and patient demographics. North America dominates the market, driven by high healthcare spending, well-established reimbursement frameworks, and the availability of advanced medical technologies. Europe is witnessing steady growth, fueled by the rising incidence of sacroiliac joint disorders and a growing preference for minimally invasive procedures. Meanwhile, the Asia-Pacific region represents a burgeoning market with immense potential due to increasing healthcare investments, rising awareness about SI joint dysfunctions, and a rapidly aging population. Governments in emerging economies like India and China are focusing on expanding healthcare access, creating opportunities for market penetration. Additionally, the Middle East and Africa are gradually adopting MIS techniques, spurred by improvements in healthcare infrastructure and increased medical tourism.

What Is Driving Growth in the MIS Sacroiliac Joint Fusion Market?

The growth in the MIS sacroiliac joint fusion market is driven by several factors, including advancements in surgical technology and evolving patient preferences. The rising prevalence of lower back pain and related conditions, particularly among older adults and physically active individuals, has created a robust demand for effective and minimally invasive treatments. Increasing investments in healthcare infrastructure and R&D initiatives have facilitated the development of more efficient and patient-friendly surgical tools and implants. The growing awareness among healthcare professionals about the benefits of early intervention has led to higher adoption rates of these procedures. Furthermore, favorable reimbursement policies in developed regions and the expanding availability of specialized surgical expertise in emerging markets are contributing to market growth. Together, these drivers underscore the strong potential for MIS sacroiliac joint fusion to address an ever-growing healthcare need efficiently and effectively.

SCOPE OF STUDY:

The report analyzes the MIS Sacroiliac Joint Fusion market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (MIS Sacroiliac Joint Fusion Implants, MIS Sacroiliac Joint Fusion Instruments & Equipment); Approach (Dorsal Approach, Anterior Approach); Indication (Degenerative Sacroiliitis Indication, Trauma Indication, Sacroiliac Joint Dysfunction Indication); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Camber Spine Technologies, LLC
  • CoreLink Surgical
  • CornerLoc
  • Globus Medical, Inc.
  • Life Spine, Inc.
  • Medtronic Plc
  • Microspine PLC
  • Orthofix Medical Inc.
  • PainTEQ
  • SI-BONE, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • MIS Sacroiliac Joint Fusion - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Lower Back Pain Drives Demand for MIS Sacroiliac Joint Fusion
    • Advancements in Minimally Invasive Surgical Techniques Enhance Market Adoption
    • Increasing Focus on Patient Outcomes Fuels Demand for MIS Procedures
    • Growth in Aging Population Propels Sacroiliac Joint Fusion Market Expansion
    • Role of MIS Techniques in Reducing Postoperative Recovery Times Boosts Adoption
    • Rising Use of Navigation and Robotics in MIS Sacroiliac Joint Fusion Expands Opportunities
    • Improved Awareness Among Physicians Drives Adoption of MIS Sacroiliac Procedures
    • Technological Innovations in Implant Designs Enhance Market Potential
    • Growing Focus on Ambulatory Surgical Centers Fuels Demand for MIS Procedures
    • Increasing Availability of Reimbursement Policies Propels Market Growth
    • Demand for Pain Management Solutions Drives Adoption of MIS Techniques
    • Rising Investments in R&D for Advanced MIS Sacroiliac Joint Fusion Products
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World MIS Sacroiliac Joint Fusion Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for MIS Sacroiliac Joint Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for MIS Sacroiliac Joint Fusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for MIS Sacroiliac Joint Fusion Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for MIS Sacroiliac Joint Fusion Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion Instruments & Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for MIS Sacroiliac Joint Fusion Instruments & Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for MIS Sacroiliac Joint Fusion Instruments & Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Dorsal Approach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Dorsal Approach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Dorsal Approach by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Anterior Approach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Anterior Approach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Anterior Approach by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Degenerative Sacroiliitis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Degenerative Sacroiliitis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Degenerative Sacroiliitis Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Trauma Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Trauma Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Trauma Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Sacroiliac Joint Dysfunction Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Sacroiliac Joint Dysfunction Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Sacroiliac Joint Dysfunction Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • JAPAN
    • MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • CHINA
    • MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • EUROPE
    • MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for MIS Sacroiliac Joint Fusion by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for MIS Sacroiliac Joint Fusion by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • FRANCE
    • MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • GERMANY
    • MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 110: Germany Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 122: Italy Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 125: Italy Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Italy 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 134: UK Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: UK 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: UK 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 146: Spain Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Spain Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Spain 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 149: Spain Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Spain 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 158: Russia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Russia Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Russia 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 161: Russia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Russia 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 167: Russia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Europe 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Europe 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for MIS Sacroiliac Joint Fusion by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Asia-Pacific 15-Year Perspective for MIS Sacroiliac Joint Fusion by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Asia-Pacific 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 197: Australia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Australia Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Australia 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 200: Australia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Australia 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Australia 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 206: Australia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • INDIA
    • MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 209: India Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: India Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: India 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 212: India Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: India Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: India 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: India 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 218: India Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 221: South Korea Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: South Korea Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: South Korea 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: South Korea 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: South Korea 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Asia-Pacific Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Asia-Pacific 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 245: Latin America Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 246: Latin America Historic Review for MIS Sacroiliac Joint Fusion by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Latin America 15-Year Perspective for MIS Sacroiliac Joint Fusion by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Latin America 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Latin America 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 260: Argentina Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Argentina Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Argentina 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Argentina 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Argentina 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 272: Brazil Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Brazil Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Brazil 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Brazil 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Brazil 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 284: Mexico Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Mexico Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Mexico 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Mexico 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Mexico 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Latin America Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Latin America 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Latin America 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 308: Middle East Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 309: Middle East Historic Review for MIS Sacroiliac Joint Fusion by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Middle East 15-Year Perspective for MIS Sacroiliac Joint Fusion by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Middle East 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 316: Middle East 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 323: Iran Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Iran Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 325: Iran 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 326: Iran Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 328: Iran 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 331: Iran 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 332: Iran Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 335: Israel Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Israel Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 337: Israel 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 338: Israel Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 340: Israel 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 343: Israel 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 344: Israel Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Saudi Arabia Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 349: Saudi Arabia 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Saudi Arabia Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 352: Saudi Arabia 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 359: UAE Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: UAE Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 361: UAE 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 362: UAE Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: UAE Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 364: UAE 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 365: UAE Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 367: UAE 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 368: UAE Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Rest of Middle East Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 373: Rest of Middle East 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Rest of Middle East Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 376: Rest of Middle East 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030
  • AFRICA
    • MIS Sacroiliac Joint Fusion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 383: Africa Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Africa Historic Review for MIS Sacroiliac Joint Fusion by Product - MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 385: Africa 15-Year Perspective for MIS Sacroiliac Joint Fusion by Product - Percentage Breakdown of Value Sales for MIS Sacroiliac Joint Fusion Implants and MIS Sacroiliac Joint Fusion Instruments & Equipment for the Years 2015, 2025 & 2030
    • TABLE 386: Africa Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Africa Historic Review for MIS Sacroiliac Joint Fusion by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 388: Africa 15-Year Perspective for MIS Sacroiliac Joint Fusion by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgery Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 389: Africa Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for MIS Sacroiliac Joint Fusion by Approach - Dorsal Approach and Anterior Approach Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 391: Africa 15-Year Perspective for MIS Sacroiliac Joint Fusion by Approach - Percentage Breakdown of Value Sales for Dorsal Approach and Anterior Approach for the Years 2015, 2025 & 2030
    • TABLE 392: Africa Recent Past, Current & Future Analysis for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for MIS Sacroiliac Joint Fusion by Indication - Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for MIS Sacroiliac Joint Fusion by Indication - Percentage Breakdown of Value Sales for Degenerative Sacroiliitis Indication, Trauma Indication and Sacroiliac Joint Dysfunction Indication for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제